Fine Needle Aspiration and Biopsy in the Management of Ovarian Cancer Including Potential Pitfalls
Michael Deavers, MD
Professor of Clinical Pathology and Genomic Medicine Houston Methodist Hospital Houston, Texas
Donna M. Coffey, MD
Assistant Professor of Pathology and Genomic Medicine Houston Methodist Hospital Houston, Texas
Ovarian carcinoma is the most common cause of death of patients with gynecologic cancer. These neoplasms are often high grade and approximately 75% are diagnosed at advanced stage with peritoneal involvement (stage III) or distant spread (stage IV ). Currently, many patients receive neoadjuvant chemotherapy (NACT) prior to definitive surgery. The goal of NACT is to reduce morbidity and mortality and to increase the likelihood of optimal debulking. Many of these patients undergo fine needle aspiration biopsy (FNAB) of omental or pelvic tumors to determine the histologic type and grade of malignancy, and to distinguish gynecologic malignancies from other tumors. An accurate diagnosis on FNAB is critical so that the clinician can determine the role of NACT for the patient. Reaching an accurate diagnosis involves several steps, including assessment of adequacy (so that sufficient material is available for interpretation and IHC), work-up of the case, and interpretation. This webinar will cover all of these steps and will highlight potential pitfalls. A case presentation format will be used to cover the most common diagnoses, difficult diagnoses and unusual cases.
|Earn 2 credits per webinar|